Viking Therapeutics, Inc.
NASDAQ:VKTX · NASDAQ Capital Market
+$0.32 today
Vol 2.63M · Avg 2.20M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+22.20%
Period High
$42.09
Period Low
$23.09
Latest
$30.38
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Kymera Therapeutics, Inc.
NASDAQ:KYMR
$7.48B
Immunovant, Inc.
NASDAQ:IMVT
$7.20B
Praxis Precision Medicines, Inc.
NASDAQ:PRAX
$5.91B
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
$5.37B
Akero Therapeutics, Inc.
AKRO
$4.50B
Crinetics Pharmaceuticals, Inc.
NASDAQ:CRNX
$3.77B
ACADIA Pharmaceuticals Inc.
NASDAQ:ACAD
$3.67B
NewAmsterdam Pharma Company N.V.
NASDAQ:NAMS
$3.53B
Soleno Therapeutics, Inc.
SLNO
$2.76B
Ascentage Pharma Group International
NASDAQ:AAPG
$407.87M
What is the latest VKTX filing?
The latest filing shown is 3 dated Jun 3, 2026.
How many recent filings does VKTX have?
Intrinsic Alpha currently shows 20 recent filings for VKTX.
Explore More
Continue the stock analysis
Jump to another research area for this company.